Literature DB >> 31399921

Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-"EVITA" study.

Zsofia Nagy1, Zsuzsanna Kis2, Tamás Géczy2, Andras Temesvari2, Zoltan Som2, Sarolta Borbas2, Tamás Breuer2, David Molnar3, Csaba Foldesi2, Attila Kardos2.   

Abstract

PURPOSE: Iatrogenic atrial septal defect (IASD) after catheter ablation (CA) for atrial fibrillation (AF) due to transseptal puncture (TSP) can occur. The aim of this prospective study was to describe the incidence of IASD and to detect any cerebrovascular accident (CVA) after radiofrequency (RF) and cryoballoon (CB) CA.
METHODS: Between July 2014 and September 2016, 94 patients (pts) (RF; 48, CB; 46, 30 (31.9%) women, mean age = 60 ± 9.7 years) with paroxysmal AF were enrolled who underwent CA procedure for the first time. During RF ablation a single (n = 30, 62.5%) or double (n = 18, 37.5%) TSP was performed. Transoesophageal echocardiography before the procedure and at the 3-month and 12-month follow-up (FU) was accomplished. During the FU period, we evaluated the occurrence of any postprocedural CVA.
RESULTS: At the 3-month FU, IASD was detected in 17/94 (18.1%) pts; in 9/48 (18.8%) pts in the RF while in 8/46 (17.4%) pts in the CB group (p = 0.866), all of them with left-to-right shunt. In the RF group, 6/30 (20%) pts with a single TSP while 3/18 (16.7%) pts in the double TSP group had IASD (p = 0.780). 14/17 (82.4%) IASDs showed high spontaneous closure rate at the 12-month FU. None of the pts died or suffered from CVA.
CONCLUSION: Persistent IASD can occur rather frequently following AF CA. No significant difference was observed between the RF and CB techniques concerning the presence of IASD at 3-month. IASDs showed a high spontaneous closure rate. No cerebral thromboembolic event was observed in the 12-month FU period.

Entities:  

Keywords:  Atrial fibrillation; Cryoballoon ablation; Iatrogenic atrial septal defect; Radiofrequency ablation; Transseptal puncture

Mesh:

Year:  2019        PMID: 31399921     DOI: 10.1007/s10840-019-00598-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  19 in total

1.  Impact of transseptal puncture site on acute and mid-term outcomes during cryoballoon ablation: a comparison between anterior, medial and posterior transatrial access.

Authors:  Gian-Battista Chierchia; Ruben Casado-Arroyo; Carlo de Asmundis; Moises Rodriguez-Manero; Andrea Sarkozy; Giulio Conte; Juan Sieira; Moises Levinstein; Giannis Baltogiannis; Giacomo di Giovanni; Ingrid Overeinder; Salvatore Ocello; Eligio Rosas; Francesco Isola; Pedro Brugada
Journal:  Int J Cardiol       Date:  2013-08-05       Impact factor: 4.164

2.  Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?

Authors:  Christoph Hammerstingl; Lars Lickfett; Kyung-Mi Jeong; Clemens Troatz; Jan-Arne Wedekind; Klaus Tiemann; Berndt Lüderitz; Thorsten Lewalter
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

3.  One Year Incidence of Atrial Septal Defect after PV Isolation: A Comparison Between Conventional Radiofrequency and Cryoballoon Ablation.

Authors:  Giacomo Mugnai; Juan Sieira; Giuseppe Ciconte; Marta Soriano Hervas; Ghazala Irfan; Yukio Saitoh; Burak Hünük; Erwin Ströker; Vedran Velagic; Kristel Wauters; Claudio Tondo; Giulio Molon; Carlo De Asmundis; Pedro Brugada; Gian-Battista Chierchia
Journal:  Pacing Clin Electrophysiol       Date:  2015-06-12       Impact factor: 1.976

4.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

5.  Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication.

Authors:  Ngai-Yin Chan; Chi-Chung Choy; Chun-Leung Lau; Ying-Keung Lo; Pui-Shan Chu; Ho-Chuen Yuen; Ngai-Shing Mok; Ping-Tim Tsui; Suet-Ting Lau
Journal:  Europace       Date:  2011-05-11       Impact factor: 5.214

6.  One year incidence of iatrogenic atrial septal defect after cryoballoon ablation for atrial fibrillation.

Authors:  Juan Sieira; Gian-Battista Chierchia; Giacomo Di Giovanni; Giulio Conte; Carlo De Asmundis; Andrea Sarkozy; Steven Droogmans; Giannis Baltogiannis; Yukio Saitoh; Giusepe Ciconte; Moises Levinstein; Pedro Brugada
Journal:  J Cardiovasc Electrophysiol       Date:  2013-10-03

7.  Transseptal access for left atrial ablation: the catheter-probing techniques are not without risk.

Authors:  Heiko Lehrmann; Jens Schneider; Amir S Jadidi; Chan-Il Park; Jochen Schiebeling-Römer; Jürgen Allgeier; Thomas Arentz; Reinhold Weber
Journal:  J Cardiovasc Electrophysiol       Date:  2014-01-29

Review 8.  Transseptal left heart catheterization and the incidence of persistent iatrogenic atrial septal defects.

Authors:  Patrick M McGinty; Thomas W Smith; Jason H Rogers
Journal:  J Interv Cardiol       Date:  2011-05-04       Impact factor: 2.279

9.  Persistence of septal defects after transeptal puncture for pulmonary vein isolation procedures.

Authors:  Owen Obel; Moussa Mansour; Michael Picard; Jeremy Ruskin; David Keane
Journal:  Pacing Clin Electrophysiol       Date:  2004-10       Impact factor: 1.976

10.  Iatrogenic atrial septal defects following atrial fibrillation transcatheter ablation: a relevant entity?

Authors:  Matteo Anselmino; Marco Scaglione; Alberto Battaglia; Silvia Muccioli; Davide Sardi; Giuseppe Azzaro; Lucia Garberoglio; Salvatore Miceli; Fiorenzo Gaita
Journal:  Europace       Date:  2014-02-18       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.